Glenmark Life Sciences Ltd.
Snapshot View

379.50 +2.70 ▲0.7%

07 October 2022, 04:01:00 PM
Volume: 15,842

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.glenmarklifesciences.com
Market Cap 4,649.91 Cr.
Enterprise Value(EV) 4,137.74 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 34.81 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 10.90 Trailing Twelve Months Ending 2022-06
Industry PE 31.91 Trailing Twelve Months Ending 2022-06
Book Value / Share 176.25 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.15 Calculated using Price: 379.50
Dividend Yield 5.53 Period Ending 2022-03
No. of Shares Subscribed 12.25 Cr. 122,527,172 Shares
FaceValue 2
Company Profile
The company is in the business of making high-quality drugs by unlocking the possibilities of science.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.72%
1 Week
-1.51%
1 Month
-13.53%
3 Month
-16.32%
6 Month
-24.99%
1 Year
-43.26%
2 Year
5 Year
10 Year
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 451.05 127.84 60.91 29.87
Return on Capital Employed (%) 527.74 185.60 96.75 42.24
Return on Assets (%) -510.59 26.51 19.56 17.82 16.57

Balance Sheet View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds -1 88 402 753 2,054
Non Curr. Liab. 7 16 23 33
Curr. Liab. 1 1,380 1,307 1,445 747
Minority Int.
Equity & Liab. 0 1,475 1,726 2,221 2,834
Non Curr. Assets 545 565 598 706
Curr. Assets 0 931 1,160 1,623 2,127
Misc. Exp. not W/O
Total Assets 0 1,475 1,726 2,221 2,834

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 0 886 1,537 1,885 2,123 2,088
Other Income 1 12 1 15 20
Total Income 0 887 1,549 1,886 2,138 2,108
Total Expenditure 0 -639 -1,065 -1,294 -1,507 -1,486
PBIDT 0 248 484 592 631 623
Interest -1 -34 -88 -28 -8
Depreciation -19 -29 -33 -38 -39
Taxation 0 -33 -108 -119 -146 -150
Exceptional Items
PAT 0 196 313 352 419 427
Adjusted EPS -8 18 29 33 34 35

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 10 195 388 598
Cash Fr. Inv. -9 -51 -69 -122
Cash Fr. Finan. 0 1 -137 -214 -79
Net Change 0 2 8 106 397
Cash & Cash Eqvt 0 2 10 116 512

Shareholding Pattern View Details >>

4 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 82.84 82.85 82.85 82.85
Public 17.16 17.15 17.15 17.15
Depository Receipts 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 26 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Proceedings and Scrutinizers Report of the 11th Annual General Meeting (AGM) of Glenmark Life Sciences Limited (the Company) held on September 26 2022
Mon, 26 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings and Scrutinizers Report of the 11th Annual General Meeting (AGM) of Glenmark Life Sciences Limited (the Company) held on September 26 2022
Thu, 01 Sep 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of Notice of 11th Annual General Meeting E-voting Information and Book Closure

Technical Scans View Details >>

Fri, 07 Oct 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,656.62 953.00 -0.1%
Divi's Laboratories Ltd. 99,250.74 3,738.70 +0.0%
Cipla Ltd. 91,332.41 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 72,821.94 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,207.02 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 53,000.56 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,689.71 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.79 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.96 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.70 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.35 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.55 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.17 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.66 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.56 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.25 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.60 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.64 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.54 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Glenmark Life Sciences Ltd.

What is Glenmark Life Scienc share price?

Can I buy Glenmark Life Scienc shares now?

What is the Dividend Yield of Glenmark Life Scienc?

What is the Market Cap of Glenmark Life Scienc?

What are the key metrics to analyse Glenmark Life Scienc?

What is the 52 Week High and Low of Glenmark Life Scienc?

What is the trend of Glenmark Life Scienc share price?